Datwyler with Strong Momentum in the First Half

Datwyler generated sales of CHF 563.0 million in the first half of 2025 (previous year CHF 572.5 million). On a currency-adjusted basis, this represents year-over-year growth of 1.3%. Compared to the second half of 2024, growth amounted to 5.2%. Key drivers of this performance were the launch of new, attractive Healthcare products and positive developments in the Food & Beverage segment, largely offsetting weaker demand in the automotive business. A significant appreciation of the Swiss franc reduced sales by CHF 16.7 million or 2.9%; however, operational impact remained minimal.

Operating profit (EBIT) increased despite negative currency effects, reaching CHF 68.9 million (previous year CHF 67.5 million), which corresponds to an improved EBIT margin of 12.2% (previous year 11.8%). This performance was primarily driven by operational leverage, an improved product mix, efficiency gains, and targeted cost reductions. Slightly higher financial expenses and higher tax expenses resulted in a net income of CHF 37.9 million (previous year CHF 38.6 million). Earnings per share came to CHF 2.23 (previous year CHF 2.27). Both divisions successfully secured new business in the first six months, building a solid project pipeline – further evidence of the strong market position as a trusted partner for system-critical elastomer components in demanding applications.

In the first half of 2025, Datwyler delivered a strong performance and made important progress despite a challenging environment. Guided by our strategic priorities and our ForwardNow program, we are following a clear plan – and executing it with discipline. We are on track and look to the future with confidence, supported by the long-term growth trends in our markets

Volker Cwielong

CEO

Healthcare Division: Demand Recovery and Successful Ramp-Up of New Projects

The Healthcare division achieved currency-adjusted sales growth of 5.8% to CHF 236.8 million (previous year CHF 230.7 million) in the first half of 2025. After a cautious start to the year, demand accelerated noticeably in the second quarter, signaling that customer destocking has largely been completed and the market is normalizing. Several projects involving NeoFlex plungers for prefilled syringes successfully entered series production. Component manufacturing for a leading weight-loss medication (GLP-1) also started as planned. EBIT grew by 12.6% to CHF 40.1 million (previous year CHF 35.6 million), while the EBIT margin improved by 150 basis points to 16.9% (previous year 15.4%). This positive trend reflects higher plant utilization, an enhanced product mix, targeted efficiency improvements, and a more value-driven sales approach.

Industrial Division: Trade Conflicts Weigh on Demand – Focus on High-Margin Projects

The Industrial division recorded revenue of CHF 329.3 million in the first half of the year (previous year CHF 343.4 million), representing a currency-adjusted decline of 1.4%. Ongoing trade and tariff conflicts created uncertainty and muted demand across various industrial markets; however, Datwyler remains well positioned thanks to its local production strategy. Local sales of products for battery-electric vehicles in China continued to perform positively. In contrast, demand recovery in the energy market fell short of expectations. Even in a challenging environment, Datwyler maintains a clear focus on innovative, high-margin products. The Food & Beverage business delivered solid growth, supported by new supply agreements and capacity expansions for coffee capsules. EBIT reached CHF 28.8 million (previous year CHF 31.9 million), corresponding to a margin of 8.7% (previous year 9.3%).

Transformation Program ForwardNow on Track

Launched in December 2024, the ForwardNow program is already showing strong progress. Planned optimization measures are taking effect, and we expect to achieve the targeted contribution for 2025. The program focuses on four key areas: optimizing the production network, enhancing commercial excellence, streamlining the portfolio, and establishing a future-ready operating model.

Streamlining the U.S. Production Network

Datwyler will close its Vandalia (Ohio) site by the end of September 2025, consolidating production and distribution into two existing U.S. facilities. This will not only streamline our production footprint but also optimize our product and customer portfolio.

More Efficient Corporate Structure and Realignment of the Industrial Division

The corporate function for Sustainability & Operational Excellence has been integrated into existing structures. As of June 1, 2025, the Executive Committee has been reduced to five members and focuses on the Healthcare and Industrial divisions as well as the Finance and Technology & Innovation functions.

As of April 1, 2025, the Mobility and Connectors business units were merged into a new Transportation & Electronics unit within the Industrial division. With clearly defined regional sales responsibilities and a modular organizational model – structured by regions and global product lines – the organization is now better positioned. Regional production units now report directly to the division head, enabling better synergies across the value chain.

Outlook: Better positioned for Continued Growth

For the second half of 2025, we expect different trends in the Datwyler’s sales markets. In the Industrial division, sentiment in automotive and industrial markets will continue to be influenced by global trade and tariff developments. Thanks to our globally aligned production strategy with facilities in Asia, Europe, and the Americas, both divisions are well-positioned. While direct impacts of the tariff conflicts remain limited, prevailing uncertainties continue to weigh on investment appetite in some markets. In the Food & Beverage unit, we expect robust demand and sales growth, supported by additional supply agreements and expanded production capacity.

In the Healthcare division, we are confident that the recovery and growth trends will continue in the second half of the year. The ramp-up of new components for attractive customer projects, combined with growing demand in existing programs, should further support volume growth. We expect that these factors will largely offset the usual seasonal slowdown in the second half, enabling continued improvements in both sales and profitability.

By making targeted investments in innovation and growth initiatives and by systematically implementing our ForwardNow transformation program, we are laying the foundation to capitalize on above-market growth in our target industries over the long term. Accordingly, we reaffirm our mid-term financial targets.